Biologist Pharmaceutical Pre-Development | Biologe pharmazeutische Vorentwicklung (m/w/d)

FERCHAU GmbH Niederlassung Giessen

Marburg, Hessen, Deutschland
Published Feb 20, 2026
Full-time
No information

Job Summary

This role focuses on the downstream process development of recombinant cells and proteins within a high-tech pharmaceutical environment. As a Biologist in Pre-Development, you will be responsible for the day-to-day handling of samples, cell cultures, and media, while actively contributing to the creation of experimental study designs using Design of Experiments (DoE) and Quality by Design (QbD) principles. You will operate and maintain advanced laboratory equipment for chromatography, filtration, and flow cytometry, specifically in a high-throughput downstream processing (DSP) context. The position offers a unique opportunity to work on complex innovation projects for renowned clients in the Life Science sector. It is particularly attractive due to its blend of high-level scientific research and practical laboratory management, supported by a flexible work environment that includes mobile work options, flex-time, and a permanent employment contract designed for long-term professional growth.

Required Skills

Education

Successfully completed degree in (Molecular) Biology, Chemistry, or another relevant natural science field.

Experience

  • Professional experience in downstream processes (DSP) for recombinant cells and proteins
  • Practical experience in handling, collecting, and processing biological samples
  • Experience in planning and evaluating scientific experiments according to Quality by Design principles
  • Experience using statistical analysis software such as JMP or R
  • Experience operating high-throughput laboratory and analytical equipment

Languages

German (Fluent)English (Fluent)

Additional

  • The role requires the ability to work in a laboratory environment following specific quality standards. Flexibility for mobile work and occasional presence for laboratory maintenance is expected.